151 related articles for article (PubMed ID: 2550572)
1. Clinical and serological outcome of genital herpes simplex virus (HSV) type 2 inoculation following oral HSV type 1 infection in guinea-pigs.
Bernstein DI; Lee FK; Echler G; Nahmias AJ
J Gen Virol; 1989 Sep; 70 ( Pt 9)():2365-72. PubMed ID: 2550572
[TBL] [Abstract][Full Text] [Related]
2. Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: effects of acyclovir.
Bernstein DI; Stanberry LR; Harrison CJ; Kappes JC; Myers MG
J Gen Virol; 1986 Aug; 67 ( Pt 8)():1601-12. PubMed ID: 3016155
[TBL] [Abstract][Full Text] [Related]
3. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type.
Lafferty WE; Coombs RW; Benedetti J; Critchlow C; Corey L
N Engl J Med; 1987 Jun; 316(23):1444-9. PubMed ID: 3033506
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes.
Stanberry LR; Bernstein DI; Burke RL; Pachl C; Myers MG
J Infect Dis; 1987 May; 155(5):914-20. PubMed ID: 3031173
[TBL] [Abstract][Full Text] [Related]
5. Antibody response to the herpes simplex virus type 2 AG-4 antigen in guinea pigs with genital herpes infections.
Maragos C; Miller A; May JT
Aust J Exp Biol Med Sci; 1986 Feb; 64 ( Pt 1)():89-95. PubMed ID: 3008691
[TBL] [Abstract][Full Text] [Related]
6. Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2.
Quenelle DC; Collins DJ; Marciani DJ; Kern ER
Vaccine; 2006 Mar; 24(10):1515-22. PubMed ID: 16288820
[TBL] [Abstract][Full Text] [Related]
7. Zosteriform spread of herpes simplex virus type 2 genital infection in the guinea-pig.
Bernstein DI; Stanberry LR
J Gen Virol; 1986 Sep; 67 ( Pt 9)():1851-7. PubMed ID: 3018127
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of an oral infection with herpes simplex virus type 1 against subsequent genital infection with herpes simplex virus type 2.
Sturn B; Schneweis KE
Med Microbiol Immunol; 1978 Jul; 165(2):119-27. PubMed ID: 209295
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of the relationship between genital herpes and carcinoma of the uterine cervix. I. Seroepidemiology of herpes simplex virus type 1 and type 2 in women with a previous history of clinically diagnosed genital herpes.
Vestergaard BF
Dev Biol Stand; 1982; 52():95-8. PubMed ID: 6299863
[TBL] [Abstract][Full Text] [Related]
10. Genital reinfection after recovery from initial genital infection with herpes simplex virus type 2 in guinea pigs.
Stanberry LR; Bernstein DI; Kit S; Myers MG
J Infect Dis; 1986 Jun; 153(6):1055-61. PubMed ID: 3009643
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus genital infection of the female guinea pig as a model for the evaluation of an experimental vaccine.
Thornton B; Baskerville A; Bailey NE; Melling JM; Hambleton P
Vaccine; 1984 Jun; 2(2):141-8. PubMed ID: 6099646
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus glycoprotein treatment of recurrent genital herpes reduces cervicovaginal virus shedding in guinea pigs.
Myers MG; Bernstein DI; Harrison CJ; Stanberry LR
Antiviral Res; 1988 Nov; 10(1-3):83-8. PubMed ID: 2852922
[TBL] [Abstract][Full Text] [Related]
13. Vaginal infection of mice with HSV type 2 variant ER-: a new animal model for human primary genital HSV type 2 infections.
Wollert KC; Fleck M; Podlech J; Weise K; Corell A; Falke D
J Virol Methods; 1992 Mar; 36(3):265-76. PubMed ID: 1313825
[TBL] [Abstract][Full Text] [Related]
14. Topical SMIP-7.7, a toll-like receptor 7 agonist, protects against genital herpes simplex virus type-2 disease in the guinea pig model of genital herpes.
Bernstein DI; Cardin RD; Bravo FJ; Earwood J; Clark JR; Li Y; Mishra P; Li C; Nayak BP; Miller AT; Wu TY; Cooke MP; Valiante NM
Antivir Chem Chemother; 2014 Apr; 23(5):189-96. PubMed ID: 23232327
[TBL] [Abstract][Full Text] [Related]
15. Recurrent genital herpes simplex virus infection in guinea pigs.
Stanberry LR; Kern ER; Richards JT; Overall JC
Intervirology; 1985; 24(4):226-31. PubMed ID: 3000982
[TBL] [Abstract][Full Text] [Related]
16. Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus.
Slomka MJ
Commun Dis Rep CDR Rev; 1996 Mar; 6(3):R41-5. PubMed ID: 8820192
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus glycoprotein immunotherapy of recurrent genital herpes: factors influencing efficacy.
Stanberry LR; Harrison CJ; Bernstein DI; Burke RL; Shukla R; Ott G; Myers MG
Antiviral Res; 1989; 11(4):203-14. PubMed ID: 2545166
[TBL] [Abstract][Full Text] [Related]
18. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.
Wald A; Zeh J; Selke S; Warren T; Ryncarz AJ; Ashley R; Krieger JN; Corey L
N Engl J Med; 2000 Mar; 342(12):844-50. PubMed ID: 10727588
[TBL] [Abstract][Full Text] [Related]
19. Impact of immunization with glycoprotein D2/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected.
Bourne N; Milligan GN; Stanberry LR; Stegall R; Pyles RB
J Infect Dis; 2005 Dec; 192(12):2117-23. PubMed ID: 16288376
[TBL] [Abstract][Full Text] [Related]
20. [Herpes simplex virus and malignancies of female genital organs].
Cokić-Damjanović J; Horvat E; Balog A
Med Pregl; 2001; 54(9-10):432-7. PubMed ID: 11876004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
